Navigation Links
BMP Sunstone Exchanges and Calls Outstanding Notes Due May 2009
Date:3/16/2009

PLYMOUTH MEETING, Pa., March 16 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP) ("BMP Sunstone", "we" or the "Company"), today announced that the Company is calling its $12.4 million of 10.0% Secured Promissory Notes due May 1, 2009 (the "Original Notes"). In addition, the Company announced the completion of the following transactions:

    -- Exchanged $1.0 million in principal amount 10.0% senior secured
       promissory notes for $1.0 million in principal amount of 12.5% March
       Exchange Secured Convertible Notes due July 1, 2011.

    -- Issued $6.35 million in principal amount of 12.5% March Cash Secured
       Convertible Notes due July 1, 2011 to qualified institutional and
       accredited investors.

    -- Completed a registered direct public offering of $7.0 million in
       principal amount of 12.5% Subordinate Convertible Notes due July 1,
       2011.

As a result of these note financings, the Company now has an aggregate of $25 million of 12.5% notes due July 1, 2011. Due to the timing of these transactions, the Company has delayed the filing of its Form 10-K and will file a Form 12b-25 in order to secure an extension. The Company will release fourth quarter and full year 2008 financial results on Tuesday, March 17, 2009, via press release and conference call to be held at 5:00 pm ET.

David Gao, Chief Executive Officer of BMP Sunstone, commented, "This exchange completes our effort to significantly increase our financial flexibility so that we can put cash to work to grow our business, integrate our recent acquisitions and launch new products. We are particularly pleased that our existing investors have continued to support the Company. We believe we are well-positioned to capitalize on the long-term growth prospects in China's dynamic healthcare marketplace, especially during these challenging economic conditions."

Additional details regarding the note financing transactions noted above, including a description of the notes, the conversion price and repricing mechanism and the security for the March Exchange Second Convertible Notes and March Cash Second Convertible Notes, are included in two Forms 8-K filed with the Securities and Exchange Commission earlier today.

About BMP Sunstone Corporation

BMP Sunstone Corporation is a specialty pharmaceutical company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China. Currently this portfolio includes eight products under exclusive multi-year licenses for China, primarily focused on women's health and pediatrics. The Company also owns Sunstone Pharmaceutical Co. Ltd., which manufactures leading pediatric and women's health products, including two of China's most recognized brands, "Hao Wawa" and "Confort," sold through approximately 120,000 pharmacies in China. The Company also provides pharmaceutical distribution services through its subsidiaries in Beijing and Shanghai, and through its affiliate, Guangzhou Pharmaceuticals Corp. The Company has its main office in Beijing, with a US office in Plymouth Meeting, PA. For more information, please visit http://www.bmpsunstone.com .


'/>"/>
SOURCE BMP Sunstone Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. BMP Sunstone Reiterates Commitment to Quality, Innovation and Long-Term Growth at Meeting with Senior Officials
2. BMP Sunstone Announces Exchange Offer of $10.7 Million of Outstanding Secured Notes
3. BMP Sunstone to Report Third Quarter 2008 Financial Results
4. BMP Sunstone Signs Letter of Intent to Acquire Shengda Pharmaceutical Co.
5. BMP Sunstone Completes Acquisition of Shanghai Rongheng Pharmaceutical Co., Ltd
6. BMP Sunstone Announces Official Launch of Ferriprox in PRC
7. BMP Sunstone Announces Participation in June Investor Conferences
8. BMP Sunstone Reports First Quarter 2008 Financial Results
9. BMP Sunstone Donates RMB 1.2 Million to Earthquake Relief
10. BMP Sunstone Announces Participation in May Investor Conferences
11. BMP Sunstone to Report First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... , ... June 26, 2017 , ... ... staff, and consumers are seeing lots of red these days. According to recent ... charges that result from medical coding errors(1). Some studies point to Electronic Health ...
(Date:6/25/2017)... CA (PRWEB) , ... June 25, 2017 , ... FCPX ... media into an old-fashioned vintage look. FCPX LUT Vintage Volume 2 contains 60 different ... film grain for distorted looks, vignettes and blurs to single out subjects, plus much ...
(Date:6/25/2017)... Rosa, CA (PRWEB) , ... June 25, 2017 , ... ... more green and growing foliage and plants, and along with that; a humdinger of ... sensitive allergy sufferers, it also means an increase in misery-causing grass and weed pollen. ...
(Date:6/25/2017)... ... , ... June is Men’s Health Month and the focus is on prostate cancer. ... the U.S. and the third most common cause of cancer related death today; lung cancer ... will be diagnosed with prostate cancer during his lifetime. Those at highest risk ...
(Date:6/24/2017)... (PRWEB) , ... June 24, 2017 , ... ... Dental365 family. Located at 217 Portion Road in Lake Ronkonkoma, Dental365 offers patients ... and weekends so that visits to the dentist fit into their patients’ busy ...
Breaking Medicine News(10 mins):
(Date:6/5/2017)... The Cincinnati location of ... (NYSE: DPLO), has been awarded a Top Workplaces 2017 ... Results are based on an employee survey administered by WorkplaceDynamics, ... improvement. The survey measures several aspects of workplace culture, including ... ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
(Date:6/1/2017)... , June 1, 2017 Nutriceutical Holdings (NH), ... Recommended Solutions (VRS), and KD Pharma Group have decided ... Holdings by KD Pharma Group. KD Pharma Group will ... option to acquire the entire company. "We ... They are committed to growing the NH companies by ...
Breaking Medicine Technology: